Acute pituitary necrosis after multiple stimulation test;Necrose hypophysaire aigue apres test de multistimulation hypophysaire

Presse Medicale

Volumn 25, Issue 37, 1996, Pages 1827-1829

  Vergely N ^a   Millot, L ^a   Brulport, V ^a   Duthel, R ^a   Estour, B ^a  

^a SERVICE DE NEUROLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GONADORELIN; PROTIRELIN;

ADULT; ARTICLE; CASE REPORT; HISTOLOGY; HUMAN; HYPOPHYSIS ADENOMA; IATROGENIC DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROVOCATION TEST; ACUTE DISEASE; ENDOCRINE FUNCTION TEST; HYPOPHYSIS; MIDDLE AGED; PATHOLOGY; REVIEW;

ACUTE DISEASE; HUMANS; MALE; MIDDLE AGED; NECROSIS; PITUITARY FUNCTION TESTS; PITUITARY GLAND;

EID: 0030607524     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dunn PJ, Donald RA, Espiner EA. Regression of acromegaly following pituitary apoplexy. Aust N Z J Med 1975; 5:369-72.
2. Steimle R, Royer J. Oppermann A, Patard C, Jacquet G, Gehin P. Hématome post-angiographique dans un adénome de l'hypophyse. Cécité et troubles oculomoteurs régressant après intervention d'urgence. Neurochirurgie 1974; 20:599-608.
3. David NJ, Gargano FP, Glaser JS. Pituitary apoplexy in clinical perspective. Neuro-ophtalmology 1975; 8:140-65.
4. Weisberg LA. Pituitary apoplexy. Association of degenerative change in pituitary adenoma with ratiotherapy and detection by cerebral computed tomography. Am J Med 1977; 63:109-15.
5. Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery 1990; 26:980-6.
6. Shirataki K, Chihara K, Shibata Y, Tamaki N, Matsumoto S, Fujita T. Pituitary apoplexy manifested during a bromocriptine test in a patient with a growth hormone - and prolactin - producing pituitary adenoma. Neurosurgery 1988; 23:395-8.
7. Nagulesparan M, Roper J. Haemorrhage into the anterior pituitary during pregnancy after induction of ovulation with clomiphene. A case report. Br J Obstet Gynaecol 1978; 85:153-5.
8. Harvey R, Michelagnoli M, McHenry P, Currie DG, Bewsher PD. Pituitary apoplexy. Br Med J 1989; 298:258.
9. Masago A, Ueda Y, Kanai H, Nagai H, Umumera S. Pituitary apoplexy after pituitary function test: a report of two cases and review of the literature. Surg Neurol 1995; 43:158-65.
10. Chanson P, Schaison G. Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma. J Clin Endocrinol Metab 1995; 80:2267-8.
11. Morsi A, Jamal S, Silverberg JDH. Pituitary apoplexy after leuprolide administration for carcinoma of the prostate. Clin Endocrinol 1966; 44:121-4.
12. Schuval BJ, Kirschenbaum A, Wolfe D, Post KD, Levine AC. Lack of effect of a gonadotropin-releasing hormone agonist in a patient with prostate cancer and a gonadotroph adenoma. J Clin Endocrinol Metab 1996; 81:864.
13. Ando S, Hoshino T, Mihara S. Pituitary apoplexy after goserelin. Lancet 1995; 345:458.
14. Rolih CA, Ober KP. Pituitary apoplexy. Endocrinol Metab Clin North Am 1993; 22:291-302.
15. Cohen R, Bouquier D, Biot-Laporte S et al. Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients. J Clin Endocrinol Metab 1986; 62:892-8.
16. Drury PL, Belchetz PE, McDonald WI, Thomas DGT, Besser GM. Transient amaurosis and headache after thyrotropin releasing hormone. Lancet 1982; i:218-19.
17. Lever EG, Butler J, Moore P, Cox TCS, Maccabe JJ. Infarction of a growth hormone-secreting macroadenoma during a TRH test. Acta Endocrinol 1986; 112:172-9.
18. Korsic M, Lelas-Bahum B, Surdonja P, Besenski N, Horvat S, Plavsic V. Infarction of FSH-secreting pituitary adenoma. Acta Endocrinol 1984; 107:149-54.
19. Arafah BM, Taylor HC, Salazar R, Saadi H, Selman WR. Apoplexy of a pituitary adenoma after dynamic testing with gonadotropin-releasing hormone. Am J Med 1989; 87:103-5.
20. Masson EA, Atkin SL, Diver M, White MC. Pituitary apoplexy and sudden blindness following the administration of gonadotropin-releasing hormone. Clin Endocrinol 1993; 38:109-10.
21. Cimino A, Corsini R, Radaeli E, Bollati A, Giustina G. Transient amaurosis in patient with pituitary macroadenoma after intravenous gonadotropin and thyrotropin releasing hormones. Lancet 1981; ii:95.
22. Bernstein M, Hegele RA, Gentili F et al. Pituitary apoplexy associated with a triple bolus test. Case report. J Neurosurg 1984; 61:586-90.
23. Chapman AJ, Williams G, Hockley AD, London DR. Pituitary apoplexy after combined test of anterior pituitary function. Br Med J 1985; 291:26.
24. Yatsuzuka H, Kitajama T, Taguchi Y, Sakai H, Nakumura N. A case of male cystic pituitary adenoma with hyperprolactinemia. Clinical study of six cases of male prolactinoma. No Shinkei Geka 1986; 14:1601-5.
25. Kimura H, Fukushima T, Aikawa H, Tagaki T, Tomonaga M. Pituitary apoplexy in a child. Case report. Shoni no Noshinkei 1989; 14:57-62.
26. Yada O, Umezawa H, Miyaoke M. Apoplexy of a pituitary macroadenoma after a triple test. Horumon to Rinsho 1992; 40:124-7.
27. Conn PM, Crawley WF. Gonadotropin releasing hormone and its analogues. N Engl J Med 1991; 324:93-103.
28. Maccagnan P, Macedo CLD, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 1995; 80:2190-7.